10 July 2023
10 July 2023
The acquisition is part of a wound care management market that is forecast to reach $38.8bn by 2030.
The xT assay will be utilised to detect patients with HLA loss in the tumour to select TCR-Ts.
The new turbine-driven ventilator has been developed for delivering non-invasive ventilation.
As the hype around artificial intelligence intensifies it is hard to determine what is making a significant impact in the medical technology space. One area that is seeing continued support, investment and innovation is cancer imaging and the picture is becoming clearer day by day.
DrugSorb-ATR is intended to reduce the risk of bleeding by actively eliminating the drug during the surgery.
The system integrates optical tracking options through a redesigned camera with algorithms of the new Ortho Q Guidance software.
ISO 13485:2016 quality certification will include Elypta’s design and development of in vitro diagnostic test kits and software to help with the early detection of cancers.
Specialists have already undergone successful training and clinical trials are being undertaken in Geneva.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
